GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

Rating:
Neutral LGND

Ligand Pharmaceuticals Incorporated (LGND) rated Neutral by Merriman

Posted on: Tuesday,  Aug 4, 2009  8:25 AM ET by Merriman

Ligand Pharmaceuticals Incorporated
(NASDAQ: LGND) rated Neutral by Merriman.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/4/2009 8:25 AM Hold
None
17.40
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy